ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026
Element-specific global burden of cancers attributable to occupational metals (As, Be, Cd, Cr, Ni), 1990-2021: trends, SDI-linked inequalities, and explainable forecasting to 2030.
Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough several occupational metals are established or probable carcinogens, their attributable cancer burdens have rarely been compared within a unified global framework. Existing evidence is often restricted to single metals, selected cancer sites, or individual countries, leaving uncertainty about how arsenic, cadmium, chromium, nickel, and beryllium differ in long-term trajectories and Socio-demographic Index (SDI)-linked inequalities.
objectiveWe quantified the cancer burden attributable to five occupational metal exposures across global, regional, and national settings from 1990 to 2021 and examined whether these burdens converged or diverged across SDI strata. Interpretable extreme gradient boosting (XGBoost) models were then used to project metal-specific trajectories to 2030.
methodsData were obtained from the Global Burden of Disease Study 2021 and covered 206 countries and territories. The main outcomes were disability-adjusted life years (DALYs) and age-standardized DALY rates per 100,000 population. Temporal trends were assessed using estimated annual percentage changes. SDI quintiles and concentration indices were used to evaluate development-related inequalities. Metal-specific XGBoost models were developed to project age-standardized DALY rates from 2022 to 2030, and Shapley additive explanations (SHAP) were used to interpret predictor contributions.
resultsIn 2021, arsenic and nickel accounted for the largest attributable cancer burdens. From 1990 to 2021, global age-standardized DALY rates declined for most metals, but improvements were heterogeneous. Countries with higher baseline burdens generally showed larger reductions, whereas several low-middle- and middle-SDI settings had stable or increasing trajectories. Arsenic and nickel showed generally positive concentration indices, indicating greater concentration in higher-SDI countries, while cadmium, chromium, and beryllium shifted from negative or near-zero values toward positive values over time. In temporal validation, XGBoost models showed moderate performance in predicting annual log-rate changes, with R
conclusionsThe cancer burden related to occupational metal exposure has declined in some settings, but inequalities between countries and across development levels remain. Countries undergoing socioeconomic and industrial transition may face increasing relative burdens in the future and should be prioritized for occupational exposure monitoring, engineering controls, and long-term cancer prevention.
Indexed as
Identifiers
42234292What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.